Helix BioMedix Inc Receives $3,240,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=96351e19-bd2d-4160-a473-99525e6ee243&Preview=1 - Date
2/12/2009 - Company Name
Helix BioMedix Inc - Mailing Address
22118 20th Avenue SE Bothell, WA 98021 - Company Description
Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides. We are headquartered in Bothell, Washington and shares of our common stock trade over-the-counter under the symbol “HXBM.OB”. We have developed a proprietary library containing a broad and diverse array of bioactive peptides. Our patent estate covers six distinct classes of peptides, comprising more than 100,000 unique peptide sequences. Our primary commercial objective is to out-license proprietary peptides to entities that possess sales, marketing and/or manufacturing expertise. Our peptides appear to have both pharmaceutical as well as non-pharmaceutical uses including broad-spectrum topical anti-infectives, wound healing agents, and cosmeceutical peptide ingredients. - Website
http://www.helixbiomedix.com - Transaction Type
Venture Equity - Transaction Amount
$3,240,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Undisclosed
